{
  "name": "Quitsa Pharmaceuticals",
  "description": "Quitsa Pharmaceuticals, a spin-out of Salzman Lovelace Investments is focused on the development of inhaled thyroid hormone for the treatment of idiopathic pulmonary fibrosis (IPF).",
  "categoryId": 12,
  "size": "xs",
  "logoFile": "logos/quitsa_pharmaceuticals-logo.webp",
  "websiteUrl": null,
  "careersUrl": null,
  "linkedinId": null,
  "linkedinNum": null,
  "crunchbaseId": null,
  "ivcId": "A1000000322404",
  "finderId": null,
  "xId": null,
  "facebookId": null,
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": null,
      "houseNumber": null,
      "city": "קצרין",
      "lat": 32.990998,
      "lon": 35.689865
    }
  ],
  "isMultinational": false,
  "isActive": true
}